ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $54,521,000 | -58.4% | 473,475 | -63.9% | 1.25% | -66.2% |
| Q1 2019 | $131,064,000 | +107.9% | 1,313,328 | +24.8% | 3.70% | +54.1% |
| Q4 2018 | $63,043,000 | -17.1% | 1,052,647 | -1.9% | 2.40% | +18.1% |
| Q3 2018 | $76,008,000 | +6.5% | 1,072,647 | 0.0% | 2.03% | +8.6% |
| Q2 2018 | $71,352,000 | +11.0% | 1,072,647 | +9.2% | 1.87% | +3.9% |
| Q1 2018 | $64,265,000 | +36414.2% | 982,647 | +9726.5% | 1.80% | +16263.6% |
| Q2 2015 | $176,000 | +1.1% | 10,000 | 0.0% | 0.01% | -21.4% |
| Q1 2015 | $174,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |